Supernus Pharmaceuticals Stock (SUPN)
Track Supernus Pharmaceuticals stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
SUPN
Supernus Pharmaceuticals
healthcare
$47.34
▲ +14.04 (+43.07%) past year
Market Cap
$2.77B
P/E Ratio
—
1Y Return
+43.07%
EPS (TTM)
-$0.51
Read the latest TheStreet Pro articles mentioning Supernus Pharmaceuticals, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
4 articlesDaily Diary Mentions
0 mentionsNo diary mentions for SUPN yet.
